Free Trial

Burning Rock Biotech (BNR) Competitors

Burning Rock Biotech logo
$2.80
-0.01 (-0.36%)
(As of 11/1/2024 ET)

BNR vs. EUDA, MGRX, ENZ, XGN, CCM, ATIP, TOI, RNLX, PMD, and MRAI

Should you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include EUDA Health (EUDA), Mangoceuticals (MGRX), Enzo Biochem (ENZ), Exagen (XGN), Concord Medical Services (CCM), ATI Physical Therapy (ATIP), Oncology Institute (TOI), Renalytix (RNLX), Psychemedics (PMD), and Marpai (MRAI). These companies are all part of the "healthcare" industry.

Burning Rock Biotech vs.

EUDA Health (NASDAQ:EUDA) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, risk, dividends, institutional ownership, media sentiment and profitability.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
EUDA Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Burning Rock Biotech
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

EUDA Health has a beta of 0.01, indicating that its stock price is 99% less volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.14, indicating that its stock price is 86% less volatile than the S&P 500.

4.4% of EUDA Health shares are held by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, EUDA Health and EUDA Health both had 1 articles in the media. EUDA Health's average media sentiment score of 1.43 beat Burning Rock Biotech's score of 0.63 indicating that EUDA Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
EUDA Health
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Burning Rock Biotech
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

EUDA Health has higher earnings, but lower revenue than Burning Rock Biotech.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
EUDA Health$3.71M28.15-$10.04MN/AN/A
Burning Rock Biotech$509.81M0.06-$92.07M-$4.80-0.58

EUDA Health has a net margin of 0.00% compared to Burning Rock Biotech's net margin of -111.25%. EUDA Health's return on equity of 0.00% beat Burning Rock Biotech's return on equity.

Company Net Margins Return on Equity Return on Assets
EUDA HealthN/A N/A N/A
Burning Rock Biotech -111.25%-74.96%-53.82%

Burning Rock Biotech received 5 more outperform votes than EUDA Health when rated by MarketBeat users.

CompanyUnderperformOutperform
EUDA HealthN/AN/A
Burning Rock BiotechOutperform Votes
5
31.25%
Underperform Votes
11
68.75%

Summary

EUDA Health beats Burning Rock Biotech on 6 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BNR vs. The Competition

MetricBurning Rock BiotechMedical laboratories IndustryBusiness SectorNASDAQ Exchange
Market Cap$28.68M$2.57B$6.56B$8.53B
Dividend YieldN/A1.69%2.62%4.14%
P/E Ratio-0.5830.5039.5915.18
Price / Sales0.06190.99214.9292.77
Price / CashN/A507.8324.8834.07
Price / Book0.274.414.555.02
Net Income-$92.07M-$31.39M$114.67M$225.46M
7 Day Performance-0.71%1.46%-0.73%0.37%
1 Month Performance-22.65%-1.36%-0.13%3.57%
1 Year Performance-70.53%35.71%23.53%29.44%

Burning Rock Biotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BNR
Burning Rock Biotech
0.4967 of 5 stars
$2.80
-0.4%
N/A-70.3%$28.68M$509.81M-0.581,390Gap Down
EUDA
EUDA Health
1.6438 of 5 stars
$4.52
-0.7%
N/A+311.7%$111.32M$3.71M0.002Positive News
MGRX
Mangoceuticals
1.4168 of 5 stars
$2.47
+1.6%
N/A-98.5%$61.30M$866,792.00-0.383News Coverage
ENZ
Enzo Biochem
0.5822 of 5 stars
$1.16
+2.7%
N/A-15.7%$59.69M$33.34M0.00520Dividend Announcement
Analyst Forecast
News Coverage
High Trading Volume
XGN
Exagen
4.1971 of 5 stars
$2.51
-3.1%
$7.00
+178.9%
+48.6%$43.64M$56.66M-2.59220Negative News
CCM
Concord Medical Services
1.6687 of 5 stars
$7.58
+2.0%
N/AN/A$32.90M$471.70M0.00970Analyst Forecast
Short Interest ↓
News Coverage
Gap Down
ATIP
ATI Physical Therapy
1.6517 of 5 stars
$5.68
-2.9%
N/A-19.3%$24.97M$729.33M-0.425,600Upcoming Earnings
Short Interest ↓
News Coverage
High Trading Volume
TOI
Oncology Institute
2.3103 of 5 stars
$0.32
flat
$2.50
+693.7%
-85.7%$23.45M$361.07M-0.40660Gap Down
RNLX
Renalytix
1.2397 of 5 stars
$0.21
+5.7%
$3.00
+1,348.6%
-79.7%$17.18M$2.29M-0.53100Gap Up
PMD
Psychemedics
N/A$2.31
-0.4%
N/A-6.5%$13.41M$20.79M-2.96140Positive News
MRAI
Marpai
N/A$0.90
+11.1%
$6.00
+566.7%
+76.9%$12.37M$37.15M-0.27150

Related Companies and Tools


This page (NASDAQ:BNR) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners